A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer

NCT04827810 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Advanced Solid Tumor

Interventions

DRUG: Gamitrinib

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]
[object Object]